These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3932057)

  • 41. Benzodiazepine concentrations in brain directly reflect receptor occupancy: studies of diazepam, lorazepam, and oxazepam.
    Greenblatt DJ; Sethy VH
    Psychopharmacology (Berl); 1990; 102(3):373-8. PubMed ID: 1979181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
    Noyes R; Garvey MJ; Cook B; Suelzer M
    Am J Psychiatry; 1991 Apr; 148(4):517-23. PubMed ID: 2006699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment.
    Fontaine R; Chouinard G; Annable L
    Am J Psychiatry; 1984 Jul; 141(7):848-52. PubMed ID: 6145363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The contribution of the active metabolites to the tolerance developing to diazepam in man: relationship to bioassayed serum benzodiazepine levels.
    Aranko K; Mattila MJ; Seppälä T; Aranko S
    Med Biol; 1984; 62(5):277-84. PubMed ID: 6442383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alcohol and benzodiazepines generate anxiety, panic and phobias.
    Cohen SI
    J R Soc Med; 1995 Feb; 88(2):73-7. PubMed ID: 7769598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparative study on the clinical effects of oxazepam and diazepam: Relationship between plasma level and effect.
    Kanto J; Iisalo EU; Hovi-Viander M; Kangas L
    Int J Clin Pharmacol Biopharm; 1979 Jan; 17(1):26-31. PubMed ID: 367976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kinetics of high-dose i.v. diazepam.
    Ochs HR; Greenblatt DJ; Lauven PM; Stoeckel H; Rommelsheim K
    Br J Anaesth; 1982 Aug; 54(8):849-52. PubMed ID: 6809023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure.
    Mintzer MZ; Griffiths RR
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):259-67. PubMed ID: 15452683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial.
    Daeppen JB; Gache P; Landry U; Sekera E; Schweizer V; Gloor S; Yersin B
    Arch Intern Med; 2002 May; 162(10):1117-21. PubMed ID: 12020181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Late-onset seizures in alcohol withdrawal.
    Mayo-Smith MF; Bernard D
    Alcohol Clin Exp Res; 1995 Jun; 19(3):656-9. PubMed ID: 7573789
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simultaneous determination of diazepam and its metabolies N-desmethyldiazepam, oxydiazepam and oxazepam in plasma and urine of man and dog by means of high-performance liquid chromatography.
    Vree TB; Baars AM; Hekster YA; van der Kleijn E; O'Reilly WJ
    J Chromatogr; 1979 Apr; 162(4):605-14. PubMed ID: 43333
    [No Abstract]   [Full Text] [Related]  

  • 52. Changes in "withdrawal symptoms" following discontinuation of low-dose diazepam.
    Hayward P; Wardle J; Higgitt A; Gray J
    Psychopharmacology (Berl); 1996 Jun; 125(4):392-7. PubMed ID: 8826545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in diazepam and oxazepam.
    DeVane CL; Stewart RB
    Arch Gen Psychiatry; 1984 Mar; 41(3):311. PubMed ID: 6703851
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacokinetics of benzodiazepines. Short-acting versus long-acting.
    Breimer DD; Jochemsen R; von Albert HH
    Arzneimittelforschung; 1980; 30(5a):875-81. PubMed ID: 6106488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
    Gerra G; Zaimovic A; Giusti F; Moi G; Brewer C
    Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluorescence--TLC densitometric determination of diazepam and other 1,4-benzodiazepines in serum.
    Sun SR
    J Pharm Sci; 1978 Oct; 67(10):1413-5. PubMed ID: 359776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant beta-carboline abecarnil.
    Löscher W; Hönack D
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):452-60. PubMed ID: 1352384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ciprofloxacin does not impair the elimination of diazepam in humans.
    Wijnands WJ; Trooster JF; Teunissen PC; Cats HA; Vree TB
    Drug Metab Dispos; 1990; 18(6):954-7. PubMed ID: 1981543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term diazepam therapy and clinical outcome.
    Rickels K; Case WG; Downing RW; Winokur A
    JAMA; 1983 Aug; 250(6):767-71. PubMed ID: 6348314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Optical hallucinosis during benzodiazepine withdrawal in low-dose dependence].
    Wolter-Henseler DK
    Psychiatr Prax; 1997 Nov; 24(6):309-10. PubMed ID: 9490452
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.